info@seagull-health.com
SeagullHealth
语言:
search

How well does Lynparza(Olaparib) work?

Clinical trials demonstrated significant improvement in progression-free survival across multiple cancer types.

Treatment Outcomes

Lynparza showed notable efficacy in maintaining response after platinum-based chemotherapy in ovarian cancer, reducing recurrence risk in early breast cancer, and delaying disease progression in pancreatic and prostate cancers. Benefits were particularly evident in patients with BRCA or HRR gene mutations.

Olaparib(Lynparza)
Olaparib(Lynparza)
LYNPARZA is a PARP inhibitor used for maintenance or treatment of certain...
WeChat Scan
Free Inquiry
Related articles
共 0 条
  • 1
前往
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved